Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: An example of polymorphisms in the XRCC1 gene

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 11, 2002, Pages 1279-1284

  Van Gils, Carla H ^a   Bostick, Roberd M ^b   Stern, Mariana C ^a   Taylor, Jack A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; LYCOPENE; RETINOL;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CODON; CONTROLLED STUDY; DIET; EXCISION REPAIR; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

AGED; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CAROTENOIDS; CASE-CONTROL STUDIES; CODON; DNA REPAIR; DNA-BINDING PROTEINS; EATING; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME; VITAMIN E;

EID: 0036846538     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Fleshner, N. E., and Klotz, L. H. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev., 17: 325-330, 1999
2. Vlajinac, H. D., Marinkovic, J. M., Ilic, M. D., and Kocev, N. I. Diet and prostate cancer: A case-control study. Eur. J. Cancer, 33: 101-107, 1997
3. Tzonou, A., Signorello, L. B., Lagiou, P., Wuu, J., Trichopoulos, D., and Trichopoulou, A. Diet and cancer of the prostate: A case-control study in Greece. Int. J. Cancer, 80: 704-708, 1999
4. Gann, P. H., Giovannucci, E., Willett, W., Sacks, F. M., Hennekens, C. H., and Stampfer, M. J. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res., 59: 1225-1230, 1999
5. Chan, J. M., Stampfer, M. J., Ma, J., Rimm, E. B., Willett, W. C., and Giovannucci, E. L. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol. Biomark. Prev., 8: 893-899, 1999
6. Eicholzer, M., Stahelin, H. B., Ludin, E., and Bernasconi, F. Smoking, plasma vitamins C. E. retinol, and carotene, and fatal prostate cancer: Seventeen-year follow-up of the prospective Basel study. Prostate, 38: 189-198, 1999
7. Hsing, A. W., Comstock, G. W., Abbey, H., and Polk, B. F. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J. Natl. Cancer Inst., 82: 941-946, 1990
8. Nomura, A. M., Stemmermann, G. N., Lee, J., and Craft, N. E. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol. Biomark. Prev., 6: 487-491, 1997
9. Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., Hartman, A. M., Haapakoski, J., Malila, N., Rautalahti, M., Ripatti, S., Maenpaa, H., Teerenhovi, L., Koss, L., Virolainen, M., and Edwards, B. K. Prostate cancer and supplementation with α-tocopherol and β-carotene: Incidence and mortality in a controlled trial. J. Natl. Cancer Inst., 90: 440-446, 1998
10. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R., and Coltman, C. SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E Cancer Prevention trial. J. Urol., 166: 1311-1315, 2001
11. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A., and Willett, W. C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst., 87: 1767-1776, 1995
12. Norrish, A. E., Jackson, R. T., Sharpe, S. J., and Skeaff, C. M. Prostate cancer and dietary carotenoids. Am. J. Epidemiol., 151: 119-123, 2000
13. Giovannucci, E., Rimm, E. B., Liu, Y., Stampfer, M. J., and Willett, W. A prospective study of tomato products, lycopene, and prostate cancer risk. J. Natl. Cancer Inst., 94: 391-398, 2002
14. Lu, Q. Y., Hung, J. C., Heber, D., Go, V. L., Reuter, V. E., Cordon-Cardo, C., Scher, H. I., Marshall, J. R., and Zhang, Z. F. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol. Biomark. Prev., 10: 749-756, 2001
15. Rao, A. V., Fleshner, N., and Agarwal, S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case-control study. Nutr. Cancer, 33: 159-164, 1999
16. Chen. L., Stacewicz-Sapuntzakis, M., Duncan, C., Sharifi, R., Ghosh, L., Van Breemen, R., Ashton, D., and Bowen, P. E. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst., 93: 1872-1879, 2001
17. Key, T. J., Silcocks, P. B., Davey, G. K., Appleby, P. N., and Bishop, D. T. A case-control study of diet and prostate cancer. Br. J. Cancer, 76: 678-687, 1997
18. Deneo-Pellegrini, H., De Stefani, E., Ronco, A., and Mendilaharsu, M. Foods, nutrients and prostate cancer: A case-control study in Uruguay. Br. J. Cancer, 80: 591-597, 1999
19. Matos, H. R., Di Mascio, P., and Medeiros, M. H. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch. Biochem. Biophys., 383: 56-59, 2000
20. Pollard, M., Luckert, P. H., and Sporn, M. B. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51: 3610-3611, 1991
21. Rohan, T. E., Howe, G. R., Burch, J. D., and Jain, M. Dietary factors and risk of prostate cancer: A case-control study in Ontario, Canada. Cancer Causes Control, 6: 145-154, 1995
22. Ohno, Y., Yoshida, O., Oishi, K., Okada, K., Yamabe, H., and Schroeder, F. H. Dietary β-carotene and cancer of the prostate: A case-control study in Kyoto, Japan. Cancer Res., 48: 1331-1336, 1988
23. Kolonel, L. N., Yoshizawa, C. N., and Hankin, J. H. Diet and prostatic cancer: A case-control study in Hawaii. Am. J. Epidemiol., 127: 999-1012, 1988
24. Andersson, S. O., Wolk, A., Bergstrom, R., Giovannucci, E., Lindgren, C., Baron, J., and Adami, H. O. Energy, nutrient intake and prostate cancer risk: A population-based case-control study in Sweden. Int. J. Cancer, 68: 716-722, 1996
25. Williams, A. W., Boileau, T. W., Zhou, J. R., Clinton, S. K., and Erdman, J. W., Jr. β-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol. J. Nutr., 130: 728-732, 2000
26. Mettlin, C., Selenskas, S., Natarajan, N., and Huben, R. β-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer (Phila.), 64: 605-612, 1989
27. Daviglus, M. L., Dyer, A. R., Persky, V., Chavez, N., Drum, M., Goldberg, J., Liu, K., Morris, D. K., Shekelle, R. B., and Stamler, J. Dietary β-carotene, vitamin C, and risk of prostate cancer: Results from the Western Electric Study. Epidemiology, 7: 472-477, 1996
28. Hayes, J. D., and Strange, R. C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology (Basel), 61: 154-166, 2000
29. Brooks, J. D., Weinstein, M., Lin, X., Sun, Y., Pin, S. S., Bova, G. S., Epstein, J. I., Isaacs, W. B., and Nelson, W. G. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol. Biomark. Prev., 7: 531-536. 1998
30. Rebbeck, T. R., Walker, A. H., Jaffe, J. M., White, D. L., Wein, A. J., and Malkowicz, S. B. Glutathione S-transferase-μ (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol. Biomark. Prev., 8: 283-287, 1999
31. Kelada, S. N., Kardia, S. L., Walker, A. H., Wein, A. J., Malkowicz, S. B., and Rebbeck, T. R. The glutathione S-transferase-μ and -theta genotypes in the etiology of prostate cancer: Genotype-environment interactions with smoking. Cancer Epidemiol. Biomark. Prev., 9: 1329-1334, 2000
32. Murata, M., Watanabe, M., Yamanaka, M., Kubota, Y., Ito, H., Nagao, M., Katoh, T., Kamataki, T., Kawamura, J., Yatani, R., and Shiraishi, T. Genetic polymorphisms in cytochrome P450 (CYP) 1A1. CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett., 165: 171-177, 2000
33. Lindahl, T., and Wood, R. D. Quality control by dna repair. Science (Wash. DC), 286: 1897-1905, 1999
34. Thompson, L. H., Bachinski, L. L., Stallings, R. L., Dolf, G., Weber, C. A., Westerveld, A., and Siciliano, M. J. Complementation of repair gene mutations on the hemizygous chromosome 9 in CHO: A third repair gene on human chromosome 19. Genomics, 5: 670-679, 1989
35. Mohrenweiser, H. W., Carrano, A. V., Fertitta, A., Perry, B., Thompson, L. H., Tucker, J. D., and Weber, C. A. Refined mapping of the three DNA repair genes. ERCC1, ERCC2, and XRCC1, on human chromosome 19. Cytogenet. Cell Genet., 52: 11-14, 1989
36. Caldecott, K. W., Aoufouchi, S., Johnson, P., and Shall, S. XRCC1 polypeptide interacts with DNA polymerase β and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res., 24: 4387-4394, 1996
37. Masson, M., Niedergang, C., Schreiber, V., Muller, S., Menissier-de Murcia, J., and de Murcia, G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol., 18: 3563-3571, 1998
38. Dantzer, F., Schreiber, V., Niedergang, C., Trucco, C., Flatter, E., De La Rubia, G., Oliver, J., Rolli, V., Menissier-de Murcia, J., and de Murcia, G. Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie (Paris), 81: 69-75, 1999
39. Whitehouse, C. J., Taylor, R. M., Thislethwaite, A., Zhang, H., Karimi-Busheri, F., Lasko, D. D., Weinfeld, M., and Caldecott, K. W. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell, 104: 107-117, 2001
40. Shen, M. R., Jones, I. M., and Mohrenweiser, H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58: 604-608, 1998
41. Lamerdin, J. E., Montgomery, M. A., Stilwagen, S. A., Scheidecker, L. K., Tebbs, R. S., Brookman, K. W., Thompson, L. H., and Carrano, A. V. Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics, 25: 547-554, 1995
42. Sturgis, E. M., Castillo, E. J., Li, L., Zheng, R., Eicher, S. A., Clayman, G. L., Strom, S. S., Spitz, M. R., and Wei, Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis (Lond.), 20: 2125-2129, 1999
43. Abdel-Rahman, S. Z., Soliman, A. S., Bondy, M. L., Omar, S., El-Badawy, S. A., Khaled, H. M., Seifeldin, I. A., and Levin, B. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett., 159: 79-86, 2000
44. Shen, H., Xu, Y., Qian, Y., Yu, R., Qin, Y., Zhou, L., Wang, X., Spitz, M. R., and Wei, Q. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer, 88: 601-606, 2000
45. Divine, K. K., Gilliland, F. D., Crowell, R. E., Stidley, C. A., Bocklage, T. J., Cook, D. L., and Belinsky, S. A. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat. Res., 461: 273-278, 2001
46. Duell, E. J., Millikan, R. C., Pittman, G. S., Winkel, S., Lunn, R. M., Tse, C. K., Eaton, A., Mohrenweiser, H. W., Newman, B., and Bell, D. A. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomark. Prev., 10: 217-222, 2001
47. Stern, M. C., Umbach, D. M., Van Gils, C. H., Lunn, R. M., and Taylor, J. A. DNA repair gene XRCC1 polymorphisms, smoking and bladder cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 125-131, 2001
48. Blazer, D. G., III, Umbach, D. M., Bostick, R. M., and Taylor, J. A. Vitamin D receptor polymorphisms and prostate cancer. Mol. Carcinog., 27: 18-23, 2000
49. Block, G., Hartman, A. M., Dresser, C. M., Carroll, M. D., Gannon, J., and Gardner, L. A data-based approach to diet questionnaire design and testing. Am. J. Epidemiol., 124: 453-469, 1986
50. Kolonel, L. N., Nomura, A. M., and Cooney, R. V. Dietary fat and prostate cancer: Current status. J. Natl. Cancer Inst., 91: 414-428, 1999
51. Gann, P. H., Hennekens, C. H., Sacks, F. M., Grodstein, F., Giovannucci, E. L., and Stampfer, M. J. Prospective study of plasma fatty acids and risk of prostate cancer. J. Natl. Cancer Inst., 86: 281-286, 1994
52. Coffey, D. S. Similarities of prostate and breast cancer: Evolution, diet and estrogens. Urology, 57(Suppl. 4A): 31-38, 2001
53. Lunn, R. M., Langlois, R. G., Hsieh, L. L., Thompson, C. L., and Bell, D. A. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res., 59: 2557-2561, 1999
54. Willett, W., and Stampfer, M. J. Total energy intake: Implications for epidemiologic analyses. Am. J. Epidemiol., 124: 17-27, 1986
55. Cappelli, E., Carrozzino, F., Abbondandolo, A., and Frosina, G. The DNA helicases acting in nucleotide excision repair. XPD, CSB and XPB, are not required for PCNA-dependent repair of abasic sites. Eur. J. Biochem., 259: 325-330, 1999
56. Collins, A. R., Dobson, V. L., Dusinska, M., Kennedy, G., and Stetina, R. The comet assay: what can it really tell us? Mutat. Res., 375: 183-193, 1997
57. Berwick, M., and Vineis, P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst., 92: 874-897, 2000
58. Watson, M. A., Olshan, A. F., Weissler, M. C., and Bell, D. A. XRCC1 polymorphisms (Arg194Trp and Arg399Gln) and risk for head and neck cancer. Abstract no. 3551. Proc. Am. Assoc. Cancer Res., 41: 557, 2000
59. Nelson, H. H., Kelsey, K. T., Taliaferro, R., Bronson, M., and Karagas, M. K. XRCC1 genotype and non-melanoma skin cancer: Results from a case-control study. Abstract no. 2782. Proc. Am. Assoc. Cancer Res., 41: 437, 2000
60. Duell, E. J., Wiencke, J. K., Cheng, T. J., Varkonyi, A., Zuo, Z. F., Ashok, T. D., Mark, E. J., Wain, J. C., Christiani, D. C., and Kelsey, K. T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis (Lond.), 21: 965-971, 2000
61. Matullo, G., Palli, D., Peluso, M., Guarrera, S., Carturan, S., Celentano, E., Krogh, V., Munnia, A., Tumino, R., Polidoro, S., Piazza, A., and Vineis, P. XRCC1, XRCC3, XPD polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis (Lond.), 22: 1437-1445, 2001
62. Loft, S., and Poulsen, H. E. Cancer risk and oxidative DNA damage in men. J. Mol. Med., 74: 297-312, 1996
63. Kohno, T., Shinmura, K., Tosaka, M., Tani, M., Kim, S-R., Sugimura, H., Nohmi, T., Kasai, H., and Yokota, J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene, 16: 3219-3225, 1998
64. Dherin, C., Radicella, J. P., Dizdaroglu, M., and Boiteux, S. Excision of oxidatively damaged DNA bases by the human α-hOGG1 protein and the polymorphic a hOGG1(Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res., 27: 4001-4007, 1999
65. Audebert, M., Radicella, J. P., and Dizdaroglu, M. Effect of single mutations in the OGG1 gene found in human tumors on the substrate specificity of the Ogg1 protein. Nucleic Acids Res., 28: 2672-2678, 2000
66. Hardie, L. J., Briggs, J. A., Davidson, L. A., Allan, J. M., King, R. F., Williams, G. I., and Wild, C. P. The effect of hOGG1 and gluthathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis (Lond.). 21: 167-172, 2000
67. Xu, J., Zheng, S. L., Turner, A., Isaacs, S. D., Wiley, K. E., Hawkins, G. A., Chang, B., Bleecker, E. R., Walsh, P. C., Meyers, D. A., and Isaacs, W. B. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res., 62: 2553-2557, 2002
68. Kelley, M. R., Cheng, L., Foster, R., Tritt, R., Jiang, J., Broshears, J., and Koch, M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape!/ref-I in prostate cancer. Clin. Cancer Res., 7: 824-830, 2001